ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
Pharma biotools VC deal value climbed 28.2% QoQ to $1.8 billion in Q3 2026. AI drug discovery drew more than $1 billion for the third time in four quarters, led by Chai Discovery ($400 million), Anew Labs ($290 million), and Basecamp Research ($140 million).
Tap to vote and see what everyone thinks.
Summary by ByteBrief